Clinical Trials Logo

Clinical Trial Summary

The diaphragm is the main muscle for inspiration and vital for ventilation. Multiple diagnostic modalities can be performed in the work-up of suspected diaphragm dysfunction. Fluoroscopy has traditionally been the method of choice in diagnosing diaphragm paralysis and is still widely used in clinical practice, while alternative non-invasive and accessible methods have been available. Superiority of ultrasound over fluoroscopy for the diagnosis of diaphragm dysfunction has been suggested. The primary objective of this study is to investigate the construct validity of ultrasound in diaphragm paralysis.


Clinical Trial Description

To study the sensitivity of ultrasound in diaphragm dysfunction we propose a prospective, operator-blinded, two-center, observational study. Participants will be evaluated for diaphragm dysfunction with fluoroscopy and pulmonary function testing as in standard of care. Additionally, ultrasound will be performed. Construct validity The primary objective of this study is to investigate the construct validity of ultrasound in diaphragm paralysis. Validity is defined as the degree to which an instrument truly measure the construct(s) it purports to measure. In general, three different types of validity can be distinguished: content validity, criterion validity, and construct validity. Since evaluation with gold standard testing is invasive, as explained in the introduction, criterion validity testing not a feasible option. Therefore, in this study, we use construct validity to provide evidence of validity. Construct validity is defined as the degree to which the scores of an instrument (here: ultrasound) are consistent with scores of other instruments (here: pulmonary function tests, fluoroscopy). Construct validation is often considered less powerful, however, with strong theories and specific and challenging hypothesis, it is possible to acquire substantial evidence. Therefore, specific definitions of 'diaphragm paresis' and 'diaphragm paralysis' regarding diagnostic modalities are established in this protocol before the start of the study ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05682027
Study type Observational
Source Isala
Contact wytze de Boer, M.D.
Phone +31646312031
Email w.s.de.boer@isala.nl
Status Recruiting
Phase
Start date September 5, 2023
Completion date December 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05869045 - POCUS and Respiratory Failure Prognosis Based on Diaphragmatic Dysfunction
Active, not recruiting NCT03266016 - Real-time Effort Driven VENTilator Management N/A
Completed NCT04444934 - Intra-operative Visual Examination at IDS
Recruiting NCT04098939 - Evaluation of Diaphragm Movement
Completed NCT04828408 - Diaphragm Functions in Bariatric Surgeries
Recruiting NCT03126838 - Diaphragmatic Dysfunction and Cardiac Surgery; Perioperative Assessment and Effect on Outcome N/A
Completed NCT05670327 - Diaphragmatic Ultrasound and Weaning After Lung Transplant.
Completed NCT04716504 - Surgical Anatomy of the Distal Portion of the Phrenic Nerve
Recruiting NCT04735757 - Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI
Completed NCT03704129 - Educational Programme in Diaphragm Ultrasonographic Assessment N/A
Not yet recruiting NCT05875883 - Phrenic Identification in the ICU
Not yet recruiting NCT05467332 - Tracheal Positive Pressure During High Flow Nasal Oxygen Administration in Critically Ill Patients: a Physiologic Study.
Completed NCT03539640 - Effect PEEP on Diaphragm N/A
Active, not recruiting NCT05019313 - Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in the Positive COVID-19 Patient